1. Home
  2. OVBC vs CRDL Comparison

OVBC vs CRDL Comparison

Compare OVBC & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

HOLD

Current Price

$47.12

Market Cap

220.0M

Sector

Finance

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.11

Market Cap

226.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVBC
CRDL
Founded
1872
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.0M
226.6M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
OVBC
CRDL
Price
$47.12
$1.11
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $8.49
AVG Volume (30 Days)
15.1K
★ 1.3M
Earning Date
11-03-2026
11-12-2026
Dividend Yield
★ 2.13%
N/A
EPS Growth
★ 42.67
N/A
EPS
★ 1.53
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$30.49
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.18
$0.88
52 Week High
$51.25
$2.34

Technical Indicators

Market Signals
Indicator
OVBC
CRDL
Relative Strength Index (RSI) 64.43 26.44
Support Level $46.54 $0.95
Resistance Level $47.05 $1.35
Average True Range (ATR) 0.97 0.07
MACD 0.16 0.00
Stochastic Oscillator 85.05 10.05

Price Performance

Historical Comparison
OVBC
CRDL

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Share on Social Networks: